Purchase Order 75N92018P00035

The National Heart Lung and Blood Institute awarded a purchase order to Trustees of Boston University (doing business as Boston University Medical Campus) valued at $24,937.50 on September 12, 2017, with completion scheduled for September 24, 2018. Work is performed in Roxbury, Massachusetts. The purchase order supports the Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells (BHIPSC-Lung) project under firm fixed-price terms with no set-aside designation. This order falls...

<p>The National Heart, Lung and Blood Institute awarded a purchase order to Trustees of Boston University valued at $99,063.00 for assay analysis services, with an award date of July 11, 2018 and ultimate completion date of September 24, 2019. Work is performed in Roxbury, Massachusetts. The order carries firm fixed price pricing and no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Trustees of Boston University for $79,654 on July 27, 2017. The order, for analytical support services, carries no set-aside designation and is priced on a firm fixed price basis. Performance takes place in Bethesda, Maryland, with an ultimate completion date of March 19, 2018.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Trustees of Boston University for $26,000.00, firm fixed price, with an award date of June 10, 2026 and ultimate completion date of June 9, 2027. The order covers Framingham Heart Study integration services. Work is performed at Boston University Medical Campus in Roxbury, Massachusetts. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Georgetown University valued at $173,950.96 on May 2, 2023, for tissue culture and biobanking shared resource services, with completion by May 1, 2026. Work is performed in Washington, DC. The order carries firm fixed-price pricing and was issued as a standalone procurement without a small business set-aside.</p>

This is a Firm Fixed Price Delivery Order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, to Trustees of Boston University (doing business as Boston University Medical Campus) for the establishment of a &quot;Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells (BHIPSC-Lung).&quot; The contract has a ceiling value of $644,020.00 and a period of performance through May 1, 2030. The contract is not set...

<p>The National Heart Lung and Blood Institute awarded a purchase order to University of Massachusetts Lowell for $20,259.87 on September 1, 2018, for laboratory support services, with final completion on August 31, 2019. No set-aside was applied. Work is performed in Lowell, Massachusetts. The contract is firm fixed price.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to New York University School of Medicine valued at $11,864.00, awarded on March 7, 2018, with ultimate completion on March 14, 2019. The order is a firm fixed-price acquisition with no set-aside. Performance takes place in New York, NY. The source does not specify the goods or services procured.</p>

This is a $105,300.00 firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) to the Trustees of Boston University for DNA extraction services on 3,000 samples for the Framingham Heart Study (FHS). The contract has a completion date of January 4, 2025 and was awarded on January 5, 2024. The contract does not have a set-aside designation. As a leading private...

The Trustees of Boston University, doing business as Boston University Medical Campus, has been awarded a delivery order against an unspecified government-wide acquisition contract by the National Institutes of Health's National Heart, Lung and Blood Institute. Valued at approximately $1.2 million, this cost-no-fee task order covers the period from April 1, 2019 through March 31, 2020 to support the Framingham Heart Study. As the prime contractor, Boston University will perform work related to...